The road less travelled

IF 72.5 1区医学 Q1 ONCOLOGY

Nature Reviews Cancer Pub Date : 2024-06-21 DOI:10.1038/s41568-024-00720-8

引用次数: 0

Abstract

In our Roadmap articles, we ask authors to provide a sense of direction to a field, to encourage new lines of thinking and experimentation, as well as opportunities for collaboration. This month, Nature Reviews Cancer launches Roadmap articles, in which we ask authors to provide a sense of direction to a field to encourage new lines of thinking and experimentation, as well as opportunities for collaboration.

查看原文本刊更多论文

少有人走的路

在 "路线图 "文章中，我们请作者为某一领域指明方向，鼓励新的思路和实验，并提供合作机会。本月，《自然-癌症评论》（Nature Reviews Cancer）推出路标文章，我们请作者为某一领域指明方向，鼓励新思路、新实验以及合作机会。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Nature Reviews Cancer 医学-肿瘤学

CiteScore

111.90

自引率

0.40%

发文量

审稿时长

6-12 weeks

期刊介绍： Nature Reviews Cancer, a part of the Nature Reviews portfolio of journals, aims to be the premier source of reviews and commentaries for the scientific communities it serves. The correct abbreviation for abstracting and indexing purposes is Nat. Rev. Cancer. The international standard serial numbers (ISSN) for Nature Reviews Cancer are 1474-175X (print) and 1474-1768 (online). Unlike other journals, Nature Reviews Cancer does not have an external editorial board. Instead, all editorial decisions are made by a team of full-time professional editors who are PhD-level scientists. The journal publishes Research Highlights, Comments, Reviews, and Perspectives relevant to cancer researchers, ensuring that the articles reach the widest possible audience due to their broad scope.